A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study

Trial Profile

A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Dysthymic disorder; Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms PRISMS
  • Most Recent Events

    • 28 Nov 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jun 2010 New source identified and integrated (University of Washington Health Sciences, 31665).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top